Source:http://linkedlifedata.com/resource/pubmed/id/18603373
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-7-15
|
pubmed:abstractText |
Changes of cardiac M2-muscarinic receptor (M2-mAChR) gene expression was investigated in type-1 like diabetic rats induced by intravenous injection of streptozotocin (STZ) and type-2 like diabetic rats induced by fed with fructose-rich chow. Systolic blood pressure (SBP) in STZ-diabetic rats was significantly lower than that in age-matched non-diabetic rats, while the SBP in type-2 like diabetic rats was higher than in non-diabetic rats. Also, the mRNA or protein level of cardiac M2-mAChR in STZ-diabetic rats was markedly higher than non-diabetic rats, but it was not observed in type-2 like diabetic rats as compared to age-matched non-diabetic rats. Arecaidine propargyl ester (APE), the agonist of M2-mAChR, produced a marked reduction of heart rate in STZ-diabetic rats but made less influence on heart rate in fructose-fed rats or non-diabetic rats. The results suggest that cardiac M2-mAChR gene expression is raised in type-1 like diabetic rats but not in type-2 like diabetic rats, this difference mainly due to hyperglycemia, for the production of hypotension in diabetic disorders.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Arecoline,
http://linkedlifedata.com/resource/pubmed/chemical/Fructose,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Muscarinic M2,
http://linkedlifedata.com/resource/pubmed/chemical/Streptozocin,
http://linkedlifedata.com/resource/pubmed/chemical/arecaidine esters
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0304-3940
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
22
|
pubmed:volume |
441
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
201-4
|
pubmed:meshHeading |
pubmed-meshheading:18603373-Animals,
pubmed-meshheading:18603373-Arecoline,
pubmed-meshheading:18603373-Blood Pressure,
pubmed-meshheading:18603373-Diabetes Mellitus, Type 1,
pubmed-meshheading:18603373-Diabetes Mellitus, Type 2,
pubmed-meshheading:18603373-Disease Models, Animal,
pubmed-meshheading:18603373-Dose-Response Relationship, Drug,
pubmed-meshheading:18603373-Fructose,
pubmed-meshheading:18603373-Gene Expression Regulation,
pubmed-meshheading:18603373-Male,
pubmed-meshheading:18603373-Myocardium,
pubmed-meshheading:18603373-RNA, Messenger,
pubmed-meshheading:18603373-Rats,
pubmed-meshheading:18603373-Rats, Wistar,
pubmed-meshheading:18603373-Receptor, Muscarinic M2,
pubmed-meshheading:18603373-Streptozocin
|
pubmed:year |
2008
|
pubmed:articleTitle |
Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.
|
pubmed:affiliation |
Department of Urology, College of Medicine and Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan, ROC.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|